---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-069895"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:48:04.792763+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# RxSight shareholders re-elect three Class III directors, approve say-on-pay, one-year frequency, and E&Y ratification

## Summary
- Three Class III directors re-elected: Julie B. Andrews, Robert J. Palmisano, Tamara R. Fountain.
- Say-on-pay approved: 22.6M for, 1.1M against, 0.4M abstain.
- Advisory vote on frequency: one-year option favored with 20.5M votes; company will hold annual say-on-pay.
- Ratification of Ernst & Young as independent auditor for FY 2024: 29.9M for, 46k against.

## SEC filing metadata
- accession: 0000950170-24-069895
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017024069895/0000950170-24-069895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017024069895/rxst-20240606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-069895
- JSON: https://secwatch.observer/filing/0000950170-24-069895.json
- Plain text: https://secwatch.observer/filing/0000950170-24-069895.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
